{"id":"https://openalex.org/W1894566","doi":null,"title":"Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.","display_name":"Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.","alternate_titles":[],"publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W1894566","mag":"1894566","pmid":"https://pubmed.ncbi.nlm.nih.gov/9608883"},"language":"en","primary_location":{"id":"mag:2401061909","doi":null,"is_oa":false,"landing_page_url":"https://repository.tno.nl/islandora/object/uuid%3A7f6595e6-a5ea-494a-a50f-8d56c6ebde89","pdf_url":null,"source":{"id":"https://openalex.org/S4210226141","display_name":"Drug Research","issn_l":"2194-9379","issn":["2194-9379","2194-9387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Arzneimittel-forschung-drug Research","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W1894566"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://resolver.tudelft.nl/uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044870115","display_name":"Bart J.M. van Vlijmen","orcid":"https://orcid.org/0000-0003-0208-6453","observed_orcids":["https://orcid.org/0000-0003-0208-6453"]},"institutions":[{"id":"https://openalex.org/I148297040","display_name":"Netherlands Organisation for Applied Scientific Research","ror":"https://ror.org/01bnjb948","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I148297040"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"B J van Vlijmen","raw_affiliation_strings":["TNO-PG, Gaubius Laboratory, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TNO-PG, Gaubius Laboratory, Leiden, The Netherlands","institution_ids":["https://openalex.org/I148297040"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N J Pearce","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N J Pearce","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038969060","display_name":"Martin O. Berg\u00f6","orcid":"https://orcid.org/0000-0002-6915-7140","observed_orcids":["https://orcid.org/0000-0002-6915-7140"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Berg\u00f6","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001127450","display_name":"Bart Staels","orcid":"https://orcid.org/0000-0002-3784-1503","observed_orcids":["https://orcid.org/0000-0002-3784-1503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Staels","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032843939","display_name":"John W. Yates","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J W Yates","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072023663","display_name":"Andrew D. Gribble","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A D Gribble","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004618639","display_name":"Brian C Bond","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B C Bond","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110491739","display_name":"Marten H. Hofker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M H Hofker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111525107","display_name":"Louis M. Havekes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L M Havekes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111831730","display_name":"Pieter H.E. Groot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P H Groot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7506,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.73009197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"48","issue":"4","first_page":"396","last_page":"402"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.7300000190734863,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.7300000190734863,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.21879999339580536,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.04839999973773956,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transgenic-mice","display_name":"transgenic mice","score":0.578000009059906},{"id":"https://openalex.org/keywords/hypolipidaemic-drugs","display_name":"hypolipidaemic drugs","score":0.8960000276565552},{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":1.0},{"id":"https://openalex.org/keywords/atp-citrate-lyase-inhibition","display_name":"ATP-citrate lyase inhibition","score":0.8230000138282776},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.7369999885559082},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/chylomicron-metabolism","display_name":"chylomicron metabolism","score":0.8270000219345093},{"id":"https://openalex.org/keywords/serum-cholesterol","display_name":"serum cholesterol","score":0.9350000023841858},{"id":"https://openalex.org/keywords/plasma-triglycerides","display_name":"plasma triglycerides","score":0.8700000047683716},{"id":"https://openalex.org/keywords/lipoprotein-lipase","display_name":"lipoprotein lipase","score":0.7549999952316284},{"id":"https://openalex.org/keywords/apolipoprotein-c-iii","display_name":"apolipoprotein C-III","score":0.8899999856948853}],"concepts":[{"id":"https://openalex.org/C2778670441","wikidata":"https://www.wikidata.org/wiki/Q384295","display_name":"Gemfibrozil","level":3,"score":0.972374677658081},{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.7689763307571411},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7226396203041077},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.7170643210411072},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7005316019058228},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.6766678690910339},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6354290246963501},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.598156750202179},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5919400453567505},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.47063207626342773},{"id":"https://openalex.org/C11772777","wikidata":"https://www.wikidata.org/wiki/Q423126","display_name":"Chylomicron","level":5,"score":0.4522382616996765},{"id":"https://openalex.org/C2780541478","wikidata":"https://www.wikidata.org/wiki/Q410020","display_name":"High-density lipoprotein","level":3,"score":0.4433914124965668},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22031137347221375}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008071","descriptor_name":"Lipoprotein Lipase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015248","descriptor_name":"Gemfibrozil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053318","descriptor_name":"Apolipoprotein E3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"mag:2401061909","doi":null,"is_oa":false,"landing_page_url":"https://repository.tno.nl/islandora/object/uuid%3A7f6595e6-a5ea-494a-a50f-8d56c6ebde89","pdf_url":null,"source":{"id":"https://openalex.org/S4210226141","display_name":"Drug Research","issn_l":"2194-9379","issn":["2194-9379","2194-9387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Arzneimittel-forschung-drug Research","raw_type":null},{"id":"pmid:9608883","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9608883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"},{"id":"pmh:oai:oai-pmh.tno.nl:13009","doi":null,"is_oa":false,"landing_page_url":"https://resolver.tno.nl/uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","pdf_url":null,"source":{"id":"https://openalex.org/S7407055233","display_name":"TNO Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Arzneimittel-Forschung/Drug Research, 48(4), pp. 396-402.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:tudelft.nl:uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","doi":null,"is_oa":false,"landing_page_url":"http://resolver.tudelft.nl/uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","pdf_url":null,"source":{"id":"https://openalex.org/S4306402238","display_name":"Repository hosted by TU Delft Library (TU Delft)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98358874","host_organization_name":"Delft University of Technology","host_organization_lineage":["https://openalex.org/I98358874"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Arzneimittel-Forschung/Drug Research, 4, 48, 396-402","raw_type":"article"},{"id":"pmh:tno:oai:tudelft.nl:uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","doi":null,"is_oa":true,"landing_page_url":"http://resolver.tudelft.nl/uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:1894566","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9608883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:tno:oai:tudelft.nl:uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","doi":null,"is_oa":true,"landing_page_url":"http://resolver.tudelft.nl/uuid:7f6595e6-a5ea-494a-a50f-8d56c6ebde89","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2019608640","https://openalex.org/W2143714107","https://openalex.org/W2066531291","https://openalex.org/W2011335404","https://openalex.org/W4240380176","https://openalex.org/W2407137401","https://openalex.org/W4238537194","https://openalex.org/W2079075512","https://openalex.org/W2051075384"],"abstract_inverted_index":{"Apolipoprotein":[0],"(APO)":[1],"E*3-Leiden":[2],"mice":[3,24,76,253],"with":[4,86,206,271],"impaired":[5],"chylomicron":[6],"and":[7,17,39,65,82,126,135,183,187,214,279],"VLDL":[8,228,246],"(very":[9],"low":[10],"density":[11,129,132],"lipoprotein)":[12],"remnant":[13],"metabolism":[14],"display":[15],"hyperlipidaemia":[16],"atherosclerosis.":[18],"In":[19,190],"the":[20,29,70,210,293],"present":[21],"study,":[22],"these":[23,232,262],"were":[25,77,142,217,234,254],"used":[26],"for":[27,292],"testing":[28,294],"hypolipidaemic":[30,259,268,299],"effect":[31,147],"of":[32,54,63,72,92,98,105,124,173,197,212,227,231,245,295,298],"two":[33],"marketed":[34],"agents,":[35],"lovastatin":[36],"(CAS":[37,41],"75330-75-5)":[38],"gemfibrozil":[40,99,213],"25812-30-0)":[42],"as":[43,45,283],"well":[44],"a":[46,60,79,110,122,170,192,224,272],"novel":[47],"compound,":[48],"SB":[49,106,166,215],"204990":[50,167,216],"(the":[51],"5-ring":[52],"lactone":[53],"+/-(3R*,5S*)":[55],"3-carboxy-11-(2,4-dichlorophenyl)-3,5-dihydroxyundecanoic":[56],"acid,":[57],"CAS":[58],"154566-12-8),":[59],"potent":[61],"inhibitor":[62],"cholesterol":[64,115,151,175,281],"fatty":[66],"acid":[67],"synthesis":[68,247],"at":[69],"level":[71],"ATP-citrate":[73],"lyase.":[74],"APOE*3-Leiden":[75],"fed":[78],"saturated":[80],"fat":[81],"cholesterol-rich":[83],"diet":[84],"supplemented":[85],"either":[87],"0.05":[88],"or":[89,95,100,102,248],"0.1%":[90],"w/w":[91,97,104],"lovastatin,":[93],"0.1":[94,101],"0.2%":[96,103],"204990.":[107],"Lovastatin":[108],"showed":[109],"dose-related":[111],"decrease":[112],"in":[113,158,169,223,242],"plasma":[114,139,149,159,174,198,238,280],"levels":[116,141,152,162],"(up":[117,163,176],"to":[118,121,164,177,202,256,261,267],"-20%)":[119],"due":[120],"lowering":[123,180],"LDL":[125,182],"HDL":[127],"(low":[128],"resp.":[130],"high":[131],"lipoprotein)-cholesterol":[133],"(-20":[134],"-18%,":[136],"respectively),":[137],"while":[138],"triglyceride":[140,161],"unaffected.":[143],"Gemfibrozil":[144],"had":[145],"no":[146],"on":[148,236],"total":[150],"but":[153],"gave":[154],"significant":[155],"dose-dependent":[156,171],"decreases":[157],"(VLDL)":[160,199],"-53%).":[165],"resulted":[168],"reduction":[172,196],"-29%)":[178],"by":[179,221],"VLDL,":[181],"HDL-cholesterol":[184],"(-50,":[185],"-20":[186],"-20%,":[188],"respectively).":[189],"addition,":[191],"strong":[193],"dose":[194],"dependent":[195],"triglycerides":[200],"up":[201],"-43%":[203],"was":[204],"observed":[205],"this":[207,287],"compound.":[208],"Although":[209],"effects":[211,230],"not":[218],"simply":[219],"explained":[220],"changes":[222],"single":[225],"determinant":[226],"metabolism--no":[229],"drugs":[233],"seen":[235],"post-heparin":[237],"lipoprotein":[239],"lipase":[240],"activity,":[241],"vivo":[243],"rate":[244],"hepatic":[249],"apoC-III":[250],"mRNA":[251],"levels--APOE*3-Leiden":[252],"found":[255],"give":[257],"robust":[258],"responses":[260],"test":[263],"compounds.":[264],"The":[265],"responsiveness":[266],"therapy":[269],"combined":[270],"clear":[273],"relationship":[274],"between":[275],"aortic":[276],"lesion":[277],"size":[278],"exposure,":[282],"demonstrated":[284],"previously,":[285],"makes":[286],"mouse":[288],"an":[289],"attractive":[290],"model":[291],"anti-atherosclerotic":[296],"properties":[297],"drugs.":[300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1894566","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
